Share：
Share this content in WeChat
X
[Chinese][PDF]4452
• Clinical Article •
Clinical value of high-resolution compressed sensing TOF-MRA in assessing Suzuki classification and the dilatation of hemorrhage related vascular in patients with moyamoya disease
LI Qing  SU Chunqiu  WU Pengfei  WU Wei  LU Shanshan 

Cite this article as: LI Q, SU C Q, WU P F, et al. Clinical value of high-resolution compressed sensing TOF-MRA in assessing Suzuki classification and the dilatation of hemorrhage related vascular in patients with moyamoya disease[J]. Chin J Magn Reson Imaging, 2023, 14(4): 29-33. DOI:10.12015/issn.1674-8034.2023.04.006.


[Abstract] Objective To explore the applied value of high-resolution compressed sensing (CS) time-of-fight magnetic resonance angiography (TOF-MRA) in assessing Suzuki classification and the dilatation of hemorrhage related vascular in patients with moyamoya disease (MMD).Materials and Methods A retrospective analysis of twenty-one receivers who underwent both CS TOF-MRA and computed tomography angiography (CTA) within 2 weeks. The scan time of CS TOF-MRA was 5 min 4 s, with a reconstructed resolution of 0.4 mm×0.4 mm×0.4 mm. Visualization of Suzuki classification, moyamoya vessel (MMV), anterior choroidal artery (AChA), and posterior communicating artery (PComA) were independently ranked by two neuroradiologists on CS TOF-MRA and CTA, respectively. The unilateral cerebral hemisphere as a unit, the dilatation of AChA and PComA were graded using both CS TOF-MRA and CTA. Wilcoxon rank sum test was used to compare the evaluation results of CS TOF-MRA and CTA.Results The evaluation ability of Suzuki classification, CS TOF-MRA was equivalent to CTA (Z=-1.000, P＞0.05). The MMV, AChA and PComA were better visualized on CS TOF-MRA than CTA (both P＜0.05). Thirty-seven hemisphere were enrolled (5 cases of unilateral MMD and 16 cases of bilateral MMD), the dilatation of AChA and PComA, were comparable to CTA (both P＜0.05).Conclusions Within a clinically reasonable time, high-resolution CS TOF-MRA outperforms CTA for visualization of hemorrhage related vascular and is equivalent to CTA for Suzuki classification and the dilatation of hemorrhage related vascular in MMD patients. High-resolution CS TOF-MRA can be used as a priority imaging examination for follow-up review of MMD patients, and has well applied value in clinical practice.
[Keywords] cerebrovascular disorders；moyamoya disease；intracranial hemorrhage；high-resolution compressed sensing；magnetic resonance angiography；magnetic resonance imaging

LI Qing1   SU Chunqiu1   WU Pengfei1   WU Wei2   LU Shanshan1*  

1 Department of Radiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

2 Department of Neurosurgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

Corresponding author: Lu SS, E-mail: lushan1118@163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS National Natural Science Foundation of China (No. 82171907).
Received  2022-11-18
Accepted  2023-04-14
DOI: 10.12015/issn.1674-8034.2023.04.006
Cite this article as: LI Q, SU C Q, WU P F, et al. Clinical value of high-resolution compressed sensing TOF-MRA in assessing Suzuki classification and the dilatation of hemorrhage related vascular in patients with moyamoya disease[J]. Chin J Magn Reson Imaging, 2023, 14(4): 29-33. DOI:10.12015/issn.1674-8034.2023.04.006.

[1]
SUZUKI J, TAKAKU A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain[J]. Arch Neurol, 1969, 20(3): 288-299. DOI: 10.1001/archneur.1969.00480090076012.
[2]
IHARA M, YAMAMOTO Y, HATTORI Y, et al. Moyamoya disease: diagnosis and interventions[J]. Lancet Neurol, 2022, 21(8): 747-758. DOI: 10.1016/S1474-4422(22)00165-X.
[3]
GUPTA A, TYAGI A, ROMO M, et al. Moyamoya disease: a review of current literature[J/OL]. Cureus, 2020, 12(8): e10141 [2022-3-12]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526970/. DOI: 10.7759/cureus.10141.
[4]
LI J C, JIN M Y, SUN X Y, et al. Imaging of moyamoya disease and moyamoya syndrome: current status[J]. J Comput Assist Tomogr, 2019, 43(2): 257-263. DOI: 10.1097/RCT.0000000000000834.
[5]
SONG X W, ZHANG Q, ZHAO J Z. Research progress in the epidemiology of moyamoya disease[J/OL]. Chin J Cerebrovasc Dis Electron Ed, 2021, 15(1): 9-15 [2022-5-10]. https://zhnxgbzz.cma-cmc.com.cn/CN/10.11817/j.issn.1673-9248.2021.01.002. DOI: 10.11817/j.issn.1673-9248.2021.01.002.
[6]
KOBAYASHI E, SAEKI N, OISHI H, et al. Long-term natural history of hemorrhagic moyamoya disease in 42 patients[J]. J Neurosurg, 2000, 93(6): 976-980. DOI: 10.3171/jns.2000.93.6.0976.
[7]
HAN Q D, YAO F R, ZHANG Z Y, et al. Evaluation of revascularization in different suzuki stages of ischemic moyamoya disease by whole-brain CT perfusion[J/OL]. Front Neurol, 2021, 12: 683224 [2022-4-3]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343098/. DOI: 10.3389/fneur.2021.683224.
[8]
SUN H G, LI W J, XIA C, et al. Angiographic and hemodynamic features in asymptomatic hemispheres of patients with moyamoya disease[J]. Stroke, 2022, 53(1): 210-217. DOI: 10.1161/STROKEAHA.121.035296.
[9]
LIU P, XIAN P, LI D S, et al. Analysis of clinical and imaging features of rebleeding in patients with moyamoya disease[J]. Chin J Cerebrovasc Dis, 2013, 10(1): 26-30. DOI: 10.3969/j.issn.1672-5921.2013.01.007.
[10]
WANG J, YANG Y, LI X, et al. Lateral posterior choroidal collateral anastomosis predicts recurrent ipsilateral hemorrhage in adult patients with moyamoya disease[J]. AJNR Am J Neuroradiol, 2019, 40(10): 1665-1671. DOI: 10.3174/ajnr.A6208.
[11]
KANG S, LIU X J, ZHANG D, et al. Natural course of moyamoya disease in patients with prior hemorrhagic stroke[J]. Stroke, 2019, 50(5): 1060-1066. DOI: 10.1161/STROKEAHA.118.022771.
[12]
WU F, HAN C, LIU Y H, et al. Validation of choroidal anastomosis on high-resolution magnetic resonance imaging as an imaging biomarker in hemorrhagic moyamoya disease[J]. Eur Radiol, 2021, 31(7): 4548-4556. DOI: 10.1007/s00330-020-07479-0.
[13]
YAMAMOTO S, HORI S, KASHIWAZAKI D, et al. Longitudinal anterior-to-posterior shift of collateral channels in patients with moyamoya disease: an implication for its hemorrhagic onset[J]. J Neurosurg, 2018, 130(3): 884-890. DOI: 10.3171/2017.9.JNS172231.
[14]
LUO Q, YU J L. Moyamoya disease with posterior communicating artery aneurysm: a case report[J]. Turk Neurosurg, 2013, 23(4): 546-550. DOI: 10.5137/1019-5149.JTN.5668-11.1.
[15]
WADDLE S L, GARZA M, DAVIS L T, et al. Presurgical magnetic resonance imaging indicators of revascularization response in adults with moyamoya vasculopathy[J]. J Magn Reson Imaging, 2022, 56(4): 983-994. DOI: 10.1002/jmri.28156.
[16]
BYWORTH M T, MOFFATT J I, PERERA K S. Novel vascular anastomoses and moyamoya disease in a woman with down syndrome[J]. Can J Neurol Sci, 2021, 48(3): 417-418. DOI: 10.1017/cjn.2020.195.
[17]
LU M M, ZHANG H T, LIU S T, et al. Long-term outcomes of moyamoya disease versus atherosclerosis-associated moyamoya vasculopathy using high-resolution MR vessel wall imaging[J/OL]. J Neurol Neurosurg Psychiatry, 2023 [2023-3-3]. https://jnnp.bmj.com/content/early/2023/03/02/jnnp-2022-330542.long. DOI: 10.1136/jnnp-2022-330542.
[18]
FENG L, BENKERT T, BLOCK K T, et al. Compressed sensing for body MRI[J]. J Magn Reson Imaging, 2017, 45(4): 966-987. DOI: 10.1002/jmri.25547.
[19]
ZHANG X, CAO Y Z, MU X H, et al. Highly accelerated compressed sensing time-of-flight magnetic resonance angiography may be reliable for diagnosing head and neck arterial steno-occlusive disease: a comparative study with digital subtraction angiography[J]. Eur Radiol, 2020, 30(6): 3059-3065. DOI: 10.1007/s00330-020-06682-3.
[20]
LI Q, LU S S, SUN T, et al. The applied research on the CS technique in intracranial MRA[J]. China Med Equip, 2020, 17(2): 66-70. DOI: 10.3969/J.ISSN.1672-8270.2020.02.018.
[21]
REN S J, WU W, SU C Q, et al. High-resolution compressed sensing time-of-flight MR angiography outperforms CT angiography for evaluating patients with Moyamoya disease after surgical revascularization[J/OL]. BMC Med Imaging, 2022, 22(1): 64 [2022-3-25]. https://bmcmedimaging.biomedcentral.com/articles/10.1186/s12880-022-00790-w. DOI: 10.1186/s12880-022-00790-w.
[22]
LIANG Z H, HE W H, HUANG Y Q, et al. Relationship between MRI performance and vascular score of MRA in adult moyamoya disease[J]. Comput Tomogr Theory Appl, 2019, 28(6): 669-675. DOI: 10.15953/j.1004-4140.2019.28.06.04.
[23]
LIU W H, ZHU S G, WANG X L, et al. Evaluation of angiographic changes of the anterior choroidal and posterior communicating arteries for predicting cerebrovascular lesions in adult moyamoya disease[J]. J Clin Neurosci, 2011, 18(3): 374-378. DOI: 10.1016/j.jocn.2010.05.032.
[24]
MORIOKA M, HAMADA J, KAWANO T, et al. Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients[J]. Stroke, 2003, 34(1): 90-95. DOI: 10.1161/01.str.0000047120.67507.0d.
[25]
TIAN B, JIANG Y, KANG Q. Comparative study of 4D CTA and DSA for vascular assessment in moyamoya disease[J]. Clin Imaging, 2018, 48: 74-78. DOI: 10.1016/j.clinimag.2017.10.005.
[26]
DUMAN I E, DEMERATH T, STADLER A, et al. High-resolution gadolinium-enhanced MR cisternography using compressed-sensing T1 SPACE technique for detection of intracranial CSF leaks[J]. AJNR Am J Neuroradiol, 2021, 42(1): 116-118. DOI: 10.3174/ajnr.A6852.
[27]
MOGHARI M H, ANNESE D, GEVA T, et al. Three-dimensional heart locator and compressed sensing for whole-heart MR angiography[J]. Magn Reson Med, 2016, 75(5): 2086-2093. DOI: 10.1002/mrm.25800.
[28]
CHEN Z Y, SUN B, XUE Y J. Comparing compressed sensing breath-hold 3D MR cholangiopancreatography with two parallel imaging MRCP strategies in main pancreatic duct and common bile duct[J/OL]. Eur J Radiol, 2021, 142: 109833 [2022-4-26]. https://www.ejradiology.com/article/S0720-048X(21)00314-4/fulltext. DOI: 10.1016/j.ejrad.2021.109833.
[29]
FUSHIMI Y, MIKI Y, KIKUTA K I, et al. Comparison of 3.0- and 1.5-T three-dimensional time-of-flight MR angiography in moyamoya disease: preliminary experience[J]. Radiology, 2006, 239(1): 232-237. DOI: 10.1148/radiol.2383042020.
[30]
YAMAMOTO T, FUJIMOTO K, OKADA T, et al. Time-of-flight magnetic resonance angiography with sparse undersampling and iterative reconstruction: comparison with conventional parallel imaging for accelerated imaging[J]. Invest Radiol, 2016, 51(6): 372-378. DOI: 10.1097/RLI.0000000000000221.
[31]
YAMAMOTO T, OKADA T, FUSHIMI Y, et al. Magnetic resonance angiography with compressed sensing: an evaluation of moyamoya disease[J/OL]. PLoS One, 2018, 13(1): e0189493 [2022-5-5]. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0189493. DOI: 10.1371/journal.pone.0189493.
[32]
LI X P, ZHANG X, ZHOU F, et al. Applications of magnetic resonance imaging in adult patients with hemorrhage moyamoya disease[J]. Chin J Magn Reson Imaging, 2019, 10(1): 57-63. DOI: 10.12015/issn.1674-8034.2019.01.011.
[33]
PILGRAM-PASTOR S, CHAPOT R, KRAEMER M. The angiographic presentation of European moyamoya angiopathy[J]. J Neurol, 2022, 269(2): 997-1006. DOI: 10.1007/s00415-021-10684-6.
[34]
SREENIVASAN S A, SURI A, RAHEJA A, et al. Effect of age, stage, and type of surgical revascularization on clinical and angiographic outcome in moyamoya disease - experience from a case series of 175 revascularization procedures[J]. Neurol India, 2022, 70(5): 2072-2081. DOI: 10.4103/0028-3886.359200.
[35]
GUO X, GAO L Y, YU H, et al. Computed tomographic angiography may be used for assessing the dilatation of the anterior choroidal and posterior communicating arteries in patients with moyamoya syndrome[J]. Eur Radiol, 2021, 31(8): 5544-5551. DOI: 10.1007/s00330-021-07722-2.
[36]
FUNAKI T, TAKAHASHI J C, HOUKIN K, et al. Effect of choroidal collateral vessels on de novo hemorrhage in moyamoya disease: analysis of nonhemorrhagic hemispheres in the Japan Adult Moyamoya Trial[J]. J Neurosurg, 2019, 132(2): 408-414. DOI: 10.3171/2018.10.JNS181139.

PREV Study on quantitative monitoring of occult injury in normal white matter regions of WMHs with different Fazekas based on DTI combined with ASL technique
NEXT The diagnostic value of 3.0 T DCE-MRI combined with DWI in differentiating pleomorphic adenoma and basal cell adenoma of salivary gland
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn